Ipsen today announced new governance in the United States, following its recently announced decision to launch Somatuline for oncology indications. Marc de Garidel will personally oversee this projected launch.
Ipsen decided to launch Somatuline for oncology indications
Wednesday, January 22, 2014
Ipsen decided to launch Somatuline for oncology indications
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment